The UK CDSS market is estimated to grow at CAGR of 12.2% during the forecast period. Major factors contributing to the UK CDSS market include the integration of technology in the healthcare sector, growing public and private investment to improvise healthcare service management, and innovation in the healthcare sector such as AI, IoT, big data and others. Additionally, high per capita healthcare expenditure and growing healthcare facilities in the country are substantially contributing to the CDSS market.
Visit for Global Clinical Decision Support System Market Report at: https://www.omrglobal.com/industry-reports/clinical-decision-support-system-market
The country has a well-developed ICT infrastructure. This developed ICT infrastructure is acting as one of the support pillars for the adoption of advanced technologies in the healthcare sector in the UK. Presence of major software companies such as IBM Corp., Google, LLC, and Microsoft Corp., are driving the market for digital technologies in the healthcare sector. For instance, Watson Health Services is the only non-NHS (National Health Services) body to support NHS England’s Health Systems Support Framework (HSSF).
The UK CDSS market is segmented on the basis of deployment, product type, and end-user. On the basis of deployment, the market is bifurcated into on-premises deployment and cloud-based deployment of CDSS. Further, on the basis of product type, the market is segmented into hardware and software & services. Software & services segment is estimated to dominate the market. Based on end-user, the market is segmented into hospitals & clinics, diagnostic centers, retail pharmacy, and others. Hospitals & Clinics segment is anticipated to have a dominating share in global CDSS market in 2018. Moreover, the study of the European CDSS market report covers the analysis of several players operating in the market. Some of the key players include Allscrips Healthcare Solutions, Inc., Cerner Corp., Koninklijke Philips N.V., and others.
Research Methodology
The market study of the UK clinical decision support system market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research has been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.
Secondary Sources Include
The report is intended for healthcare service providers, medical device companies, IT industry, software and solutions provider, technology investors, healthcare organizations, investing companies and venture capitalists, and government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, products and services offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
1. UK CDSS Market Research and Analysis by Deployment
2. UK CDSS Market Research and Analysis by Product
3. UK CDSS Market Research and Analysis by End-User
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. UK CDSS Market by Deployment Type
5.1.1. On-Premises
5.1.2. Cloud Based
5.2. UK CDSS Market by Product
5.2.1. Hardware
5.2.2. Software & Services
5.3. UK Healthcare Information System Market by End-User
5.3.1. Hospitals & Clinics
5.3.2. Diagnostic Centers
5.3.3. Retail Pharmacy
5.3.4. Others
6. Company Profiles
6.1. Allscripts Healthcare Solutions, Inc.
6.2. Cerner Corp.
6.3. Epic Systems Corp.
6.4. IBM Corp.
6.5. InterSystems Corp
6.6. Koninklijke Philips N.V.
6.7. Nuance Communications, Inc.
6.8. Oracle Corp.
1. UK CDSS MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2018-2025 ($ MILLION)
2. UK CDSS RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
3. UK CDSS MARKET RESEARCH AND ANALYSIS BY END-USER 2018-2025 ($ MILLION)
1. UK CDSS MARKET SHARE BY DEPLOYMENT, 2018 VS 2025 (%)
2. UK CDSS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
3. UK CDSS MARKET SHARE BY END-USER, 2018 VS 2025 (%)